• 1
    Wagner KS, White JM, Lucenko I, et al., Diphtheria Surveillance Network. Diphtheria in the post-epidemic period, Europe, 2000–2009. Emerg Infect Dis 2012; 18:217225.
  • 2
    DeWinter LM, Bernard KA, Romney MG. Human clinical isolates of Corynebacterium diphtheriae and Corynebacterium ulcerans collected in Canada from 1999 to 2003 but not fitting reporting criteria for cases of diphtheria. J Clin Microbiol 2005; 43:34473449.
  • 3
    Gordon C, Fagan P, Hennessey J, Baird R. Characterisation of Corynebacterium diphtheriae isolates from infected skin lesions in the Northern Territory of Australia. J Clin Microbiol 2011; 49:39603962.
  • 4
    Sing A, Heesemann J. Imported cutaneous diphtheria, Germany, 1997–2003. Emerg Infect Dis 2005; 11:343344.
  • 5
    de Benoist AC, White JM, Efstratiou A, et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis 2004; 10:511513.
  • 6
    Orouji A, Kiewert A, Filser T, et al. Cutaneous diphtheria in a German man with travel history. Acta Derm Venereol 2012; 92:179180.
  • 7
    Hart PE, Lee PY, Macallan DC, Wansbrough-Jones MH. Cutaneous and pharyngeal diphtheria imported from the Indian subcontinent. Postgrad Med J 1996; 72:619620.
  • 8
    Lindhusen-Lindhé E, Dotevall L, Berglund M. Imported laryngeal and cutaneous diphtheria in tourists returning from western Africa to Sweden, March 2012. Euro Surveill 2012;17; pii: 20189.
  • 9
    National Health and Medical Research Council, Australia Research Council and Australian Vice-Chancellors' Committee. National statement on ethical conduct in human research. Vol. 1. Canberra: Australian Government, 2007 Chapter 5:p79.
  • 10
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: Approved standard. Wayne, PA: Clinical and Laboratory Standards Institute, 2005:M100S15.
  • 11
    Efstratiou A, George RC. Laboratory guidelines for the diagnosis of infections caused by Corynebacterium diphtheriae and C. ulcerans. Commun Dis Public Health 1999; 2:250257.
  • 12
    Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. In: Approved standard. Wayne, PA: Clinical and Laboratory Standards Institute, 2006:M45A.
  • 13
    Pimenta FP, Matias GAM, Pereira GA, et al. A PCR for dtxR gene: application to diagnosis of non-toxigenic and toxigenic Corynebacterium diphtheriae. Mol Cell Probes 2008; 22:180192.
  • 14
    Nakao H, Popovic T. Development of a direct PCR assay for detection of the diphtheria toxin gene. J Clin Microbiol 1997; 35:16511655.
  • 15
    Hiroshi N, Pruckler JM, Mazurova IK, et al. Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol 1996; 34:17111716.
  • 16
    Public Health Laboratory Network. Diphtheria Laboratory Case Definition. Available at Last updated 27 January 2009. Accessed 20 July 2013.
  • 17
    Wagner KS, White JM, Neal S, et al., Diphtheria Surveillance Network. Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007–2008: a multicentre European study. Clin Microbiol Infect 2011; 17:519525.
  • 18
    Edwards B, Hunt AC, Hoskisson P. Recent cases of non-toxigenic Corynebacterium diphtheriae in Scotland: justification for continued surveillance. J Med Microbiol 2011; 60:561562.
  • 19
    Sears A, McLean M, Hingston D, et al. Cases of cutaneous diphtheria in New Zealand: implications for surveillance and management. N Z Med J 2012; 125:6471.
  • 20
    Baker M, Taylor P, Wilson E, Jones N. A case of diphtheria in Auckland—implications for disease control. N Z Public Health Rep 1998; 5:7376.
  • 21
    Wren MWD, Shetty N. Infections with Corynebacterium diphtheriae: six years' experience at an inner London teaching hospital. Br J Biomed Sci 2005; 62:14.
  • 22
    Zeegelaar JE, Faber WR. Imported tropical infectious ulcers in travelers. Am J Clin Dermatol 2008; 9:219232.
  • 23
    Zakikhany K, Efstratiou A. Diphtheria in Europe: current problems and new challenges. Future Microbiol 2012; 7:595607.
  • 24
    Lowe CF, Bernard KA, Romney MG. Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review. J Clin Microbiol 2011; 49:26642666.
  • 25
    von Hunolstein C, Scopetti F, Efstratiou A, Engler K. Penicillin tolerance amongst on-toxigenic Corynebacterium diphtheriae isolated from cases of pharyngitis. J Antimicrob Chemother 2002; 50:125128.
  • 26
    Patey O, Bimet F, Emond JP, et al. Antibiotic susceptibilities of 38 non-toxigenic strains of Corynebacteriuam diphtheriae. J Antimicrob Chemother 1995; 36:11081110.
  • 27
    Farfour E, Badell E, Zasada A, et al. Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland. J Clin Microbiol 2012; 50:173175.
  • 28
    Bergamini M, Fabrizi P, Pagani S, et al. Evidence of increased carriage of Corynebacterium spp in healthy individuals with low antibody titres against diphtheria toxoid. Epidemiol Infect 2000; 125:105112.
  • 29
    National Notifiable Diseases Surveillance System. Australian Government Department of Health and Ageing 2011. Available at: http// Last updated 15 October 2012. (Accessed 2012 Oct 15)
  • 30
    Murphy JR. Corynebacterium diphtheriae. In: Baron S, editor. Medical microbiology, 4th Ed. Galveston: University of Texas, 1996. Chapter 32. Available at: (Accessed 2012 Aug 10)
  • 31
    Gidding HF, Backhouse JL, Burgess MA, Gilbert GL. Immunity to diphtheria and tetanus in Australia: a national serosurvey. Med J Aust 2005; 183:301304.